• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Healthcare·7090.T
Share

Ligua Inc. Stocks

¥ 849Last Updated 21.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

¥ 9.03M

¥ 849
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Ligua Inc., founded in Osaka, Japan in 2004, operates as a consulting firm primarily offering management support services within the healthcare sector. The company's activities are structured across two main divisions: Orthopedic Clinic Solutions and Financial Services. In its Orthopedic Clinic Solutions segment, Ligua develops and provides specialized software, such as Ligoo POS & CRM for managing patient information in osteopathic clinics, and ReceONE, a system designed for calculating receipts for health insurance claim submissions. This division also supplies a variety of medical devices and supplies, including EMS-indepth-, an electrical muscle stimulation unit; the Thomson bed, a hydraulic-electric treatment table used for addressing pelvic and spinal misalignments; Inject Energy, a low-frequency treatment device aimed at alleviating deep tissue pain and improving muscle atrophy; and Dr.Supporter, a general medical device utilizing Integrated Functional Mineral Crystal technology to enhance blood circulation, promote fatigue recovery, ease muscle soreness and stiffness, relieve neuralgia and lower back pain, and support core strength. Furthermore, it delivers educational training consulting, including tailored programs and online client attraction strategies for orthopedic clinics, alongside medical expense billing agency services. Ligua's Financial Services arm is involved in insurance agency activities, financial instrument intermediation, and offers financial advisory services, including mediation for mergers and acquisitions, to a diverse range of businesses.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.10.2026 22:53

"Ambitions Greater Than Anyone Else's": JPMorgan Expects SpaceX Shares to Triple in Value

21.10.2026 22:20

Berkshire Hathaway shares hit a new record high—for the first time since Buffett announced his retirement

21.10.2026 22:08

A Left or Right Turn: What Investors Are Watching Ahead of the French Presidential Election

21.10.2026 21:10

Shares of Ray-Ban had their best day since 2008. Should you buy them?

21.10.2026 20:20

The Old World on New Chips: How Nvidia Is Driving the Industrial Revolution in Europe

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026